Previous Page  9 / 16 Next Page
Information
Show Menu
Previous Page 9 / 16 Next Page
Page Background

Psychological burden drives insured patients

to discontinue in vitro fertilisation

DENNY SAKKAS

When insured patients discontinue in vitro fertilisation treatment, the reason they cite is

psychological burden.

D

enny Sakkas, PhD, of Boston IVF, Waltham,

Massachusetts, explained this outcome of the

cross-sectional survey reporting, “We sought

to find out why insured patients discontinue in vitro

fertilisation treatment before they achieve a live

birth.” Their centre is a private academically affiliated

in vitro fertilisation facility.

They sent a survey about treatment termination to

905 subjects whose final in vitro fertilisation cycle

was between 2010 and 2014, who did not achieve

a live birth, and who did not return to the centre for

at least 1 year. The women completed the survey

either online or by phone. Most Mas-

sachusetts residents are covered for

six in vitro fertilisation cycles.

Thirty-six percent of 324 recipients

(n = 324) completed the survey.

Eighty-three percent of them (n=268)

were fully or partially covered for in

vitro fertilisation and were included in

the analysis. Two thirds (66%) did not

look for in vitro fertilisation at another

centre but rather discontinued treat-

ment altogether

(Figure 1

).

The top three most reported sources

of stress included:

ƒ

ƒ

Having already given in vitro fertilis-

ation their best chance (64%)

ƒ

ƒ

Feeling too anxious or depressed

to continue (51%)

ƒ

ƒ

Infertility took too much of a toll on

their relationship (39%).

Twenty-three percent of respondents

said they conceived spontaneously.

Of the remaining 34% who looked

for care at another centre, the most

common reason (60%) was that they sought a

second opinion. When asked what features might

have improved their treatment experience, the most

common responses ranged from opening hours to

stress reduction strategies (

Figure 2)

.

Dr Sakkas concluded, “The most common reason

insured patients reported discontinuing in vitro fer-

tilisation treatment was psychological burden. They

expressed a wish for stress reduction strategies. Pro-

viding such services may affect women’s decisions

to stop treatment before they achieve a live birth.”

"

When asked what features might have

improved their treatment experience, the most

common responses ranged from opening

hours to stress reduction strategies.

Figure 1.

Reasons for discontinuing treatment

Could not afford

out-of-pocket costs

Pursuing adoption

Lost insurance coverage

41%

24%

24%

19%

11%

10%

3%

Additional treatment would

have been too stressful

Recommended they

stop treatment

Pursuing a childfree life

Proceeded to egg or

sperm donation

Figure 2.

Features that would improve the treatment

experience

46%

38%

36%

35%

34%

34%

33%

Evening or weekend

office hours

Easy, immediate access to

a mental health professional

More access

to the physician

More convenient location

Drop-in, evening

support groups

Literature on

how to deal with stress

Classes on stress reduction

ASSISTED REPRODUCTIVE TECHNOLOGY

ASRM 2016 •

Elsevier Conference Series

9